Z-1535-2015 Class II Terminated

Recalled by Biocare Medical, LLC — Concord, CA

FDA device recall Z-1535-2015 was initiated by Biocare Medical, LLC on Mar 17, 2015 and is designated Class II. Reason for recall: A drop in staining intensity over time has been observed. These lots may not meet their labeled shelf life. The recall status is terminated (terminated Jun 15, 2015). Affected quantity: 44: 8 of lot 110912, 15 of lot 041913; 17 of lot 120310 and 4 of lot 110314.

Recall details

Product Type
Devices
Report Date
May 6, 2015
Initiation Date
Mar 17, 2015
Termination Date
Jun 15, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
44: 8 of lot 110912, 15 of lot 041913; 17 of lot 120310 and 4 of lot 110314

Product description

CD99 Catalog number PM008 AA; For In Vitro Diagnostic Use. Product Usage: Provides adjunctive diagnostic information following the primary diagnosis of a neoplasm by conventional histopathology methods.

Reason for recall

A drop in staining intensity over time has been observed. These lots may not meet their labeled shelf life.

Distribution pattern

Worldwide Distribution - US nationwide in the states of TX, KS, OK, NJ, LA, GA, NC, SC, VA, and the countries of Spain, Austria, Ecuador, Dominican Republic, Vietnam, Kuwait, Hungary and Israel.

Code information

Catalog number PM008 AA; Lot numbers: 110912, Exp 2015/11; 041913, Expiry 2016/04; 120313, Expiry 2016/12; 110314, Expiry 2017/11.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1535-2015
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1535-2015. Report a data issue: hello@regdatalab.com.